Acute Normovolemic Hemodilution Clinical Trial
Official title:
Acute Normovolemic Hemodilution Using Hydroxyethyl Starch (HES 130/0.4) in Patients Undergoing Off-pump Coronary Artery Bypass Grafting Surgery: Effects on Central and Peripheral Perfusion
To study the effects of Acute normovolemic hemodilution on central and peripheral perfusion in patients Undergoing off-pump coronary artery bypass grafting surgery
Status | Recruiting |
Enrollment | 50 |
Est. completion date | April 15, 2020 |
Est. primary completion date | April 15, 2020 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 40 Years to 80 Years |
Eligibility |
Inclusion Criteria: - Patients scheduled for off- pump CABG surgery Exclusion Criteria: - Ejection fraction less than 40% - Hematocrit less than 11 g/dl - patients with severe renal impairment |
Country | Name | City | State |
---|---|---|---|
Egypt | Assiut University | Assiut |
Lead Sponsor | Collaborator |
---|---|
Assiut University |
Egypt,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Central venous oxygen saturation | Central venous blood gas analysis | Intraoperative | |
Primary | The perfusion index | perfusion index derived from pulseoximetry | Intraoperative | |
Primary | Serum lactate | from arterial blood gas analysis | Intraoperative |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04369443 -
Application of Large Volume Acute Normovolemic Hemodilution in Cardiac Surgery
|
N/A | |
Recruiting |
NCT06459141 -
The Effect of Hemodilution on Intraoperative Allogeneic Transfusion (HEAL)
|
N/A |